Neutralizing Antibody Therapeutics for COVID-19

Neutralizing Antibody Therapeutics for COVID-19

The emergence of SARS-CoV-2 and subsequent COVID-19 pandemic has resulted in a significant global public health burden, leading to an urgent need for effective therapeutic strategies. In this article, we review the role of SARS-CoV-2 neutralizing antibodies (nAbs) in the clinical management of COVID...

Full description

Bibliographic Details
Main Authors:	Aeron C. Hurt, Adam K. Wheatley
Format:	Article
Language:	English
Published:	MDPI AG 2021-04-01
Series:	Viruses
Subjects:	SARS-CoV-2 COVID-19 neutralizing antibody resistance casirivimab imdevimab
Online Access:	https://www.mdpi.com/1999-4915/13/4/628

Similar Items

Clinical Management of COVID-19: A Review of Pharmacological Treatment Options
by: Ashli M. Heustess, et al.
Published: (2021-05-01)

Treatment of SARS-CoV-2 relapse with remdesivir and neutralizing antibodies cocktail in a patient with X-linked agammaglobulinaemia
by: Emanuele Palomba, et al.
Published: (2021-09-01)

Outcomes of pregnant patients treated with REGEN-COV during the COVID-19 pandemic
by: Badell, M.L, et al.
Published: (2022)

Letter to the editor: Neutralizing antibodies for the treatment of COVID-19
by: Zeqi Zhou, et al.
Published: (2021-01-01)

Scalable, Micro-Neutralization Assay for Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples
by: Richard S. Bennett, et al.
Published: (2021-05-01)

Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19
by: Yu Kaku, et al.
Published: (2021-07-01)

Sustained Neutralizing Antibodies 6 Months Following Infection in 376 Japanese COVID-19 Survivors
by: Atsushi Goto, et al.
Published: (2021-05-01)

Kinetics of Nucleocapsid, Spike and Neutralizing Antibodies, and Viral Load in Patients with Severe COVID-19 Treated with Convalescent Plasma
by: Thomas P. Thomopoulos, et al.
Published: (2021-09-01)

SARS-CoV-2 neutralizing antibody levels are correlated with severity of COVID-19 pneumonia
by: Wei Chen, et al.
Published: (2020-10-01)

Symptoms, SARS-CoV-2 Antibodies, and Neutralization Capacity in a Cross Sectional-Population of German Children
by: Otto Laub, et al.
Published: (2021-10-01)

Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients
by: Mehul S. Suthar, et al.
Published: (2020-06-01)

A Structural Landscape of Neutralizing Antibodies Against SARS-CoV-2 Receptor Binding Domain
by: Ling Niu, et al.
Published: (2021-04-01)

Development of Coronavirus Treatments Using Neutralizing Antibodies
by: Saman Fouladirad, et al.
Published: (2021-01-01)

Rapid decline of neutralizing antibodies is associated with decay of IgM in adults recovered from mild COVID-19
by: Whitney E. Harrington, et al.
Published: (2021-04-01)

Potent Molecular Feature-based Neutralizing Monoclonal Antibodies as Promising Therapeutics Against SARS-CoV-2 Infection
by: Arnaud John Kombe Kombe, et al.
Published: (2021-05-01)

Evidence of neutralizing antibodies against SARS-CoV-2 in domestic cats living with owners with a history of COVID-19 in Lima – Peru
by: Luis M. Jara, et al.
Published: (2021-12-01)

Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2
by: Julien Favresse, et al.
Published: (2021-07-01)

Different Profiles of Antibodies and Cytokines Were Found Between Severe and Moderate COVID-19 Patients
by: Yaolin Guo, et al.
Published: (2021-08-01)

Induction of Potent and Durable Neutralizing Antibodies Against SARS-CoV-2 Using a Receptor Binding Domain-Based Immunogen
by: Vikram Srivastava, et al.
Published: (2021-03-01)

A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral Compounds
by: Lara Schöler, et al.
Published: (2020-10-01)

Longitudinal Profiling of Antibody Response in Patients With COVID-19 in a Tertiary Care Hospital in Beijing, China
by: Xia Feng, et al.
Published: (2021-03-01)

A Simplified SARS-CoV-2 Pseudovirus Neutralization Assay
by: Gaetano Donofrio, et al.
Published: (2021-04-01)

COVID-19 Infection, Vaccines, and Immunity—The Antibody Response Requires Detailed Analysis
by: Nigel J. Dimmock
Published: (2021-07-01)

Nanobodies: Prospects of Expanding the Gamut of Neutralizing Antibodies Against the Novel Coronavirus, SARS-CoV-2
by: Rocktotpal Konwarh, et al.
Published: (2020-06-01)

Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals
by: Etienne Brochot, et al.
Published: (2020-10-01)

Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients
by: Anwar M. Hashem, et al.
Published: (2020-12-01)

Kinetics of Neutralizing Antibodies of COVID-19 Patients Tested Using Clinical D614G, B.1.1.7, and B 1.351 Isolates in Microneutralization Assays
by: Jenni Virtanen, et al.
Published: (2021-05-01)

Antibody Responses to Natural SARS-CoV-2 Infection or after COVID-19 Vaccination
by: Haya Altawalah
Published: (2021-08-01)

SARS-CoV-2 Reinfection in a Healthcare Worker Despite the Presence of Detectable Neutralizing Antibodies
by: Thomas Theo Brehm, et al.
Published: (2021-04-01)

Monoclonal antibody as a potential anti-COVID-19
by: Leila Jahanshahlu, et al.
Published: (2020-09-01)

Comprehensive Deep Mutational Scanning Reveals the Immune-Escaping Hotspots of SARS-CoV-2 Receptor-Binding Domain Targeting Neutralizing Antibodies
by: Keng-Chang Tsai, et al.
Published: (2021-07-01)

Comparison and Analysis of Neutralizing Antibody Levels in Serum after Inoculating with SARS-CoV-2, MERS-CoV, or SARS-CoV Vaccines in Humans
by: Sicong Yu, et al.
Published: (2021-06-01)

SARS-CoV-2 Neutralizing Antibodies: A Network Meta-Analysis across Vaccines
by: Paola Rogliani, et al.
Published: (2021-03-01)

Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients
by: Gururaj Rao Deshpande, et al.
Published: (2020-01-01)

Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 Patients
by: Bertram Flehmig, et al.
Published: (2020-11-01)

Convalescent Plasma against COVID-19: A Broad-Spectrum Therapeutic Approach for Emerging Infectious Diseases
by: Marijn Thijssen, et al.
Published: (2020-11-01)

Realizing the Potential of Anti-SARS-CoV-2 Monoclonal Antibodies for COVID-19 Management
by: Gandhi, R.T, et al.
Published: (2022)

An Effective COVID-19 Vaccine Needs to Engage T Cells
by: Karsten Sauer, et al.
Published: (2020-09-01)

VOC 202012/01 Variant Is Effectively Neutralized by Antibodies Produced by Patients Infected before Its Diffusion in Italy
by: Valeria Rondinone, et al.
Published: (2021-02-01)

Virological and Serological Discordant Profiles in COVID-19 Pneumonia: Two Atypical Clinical Cases
by: Martina Ranzenigo, et al.
Published: (2020-10-01)